Agilent launches SureCycler 8800 thermal cycler Agilent Systems, Inc. today presented the Agilent SureCycler 8800, a full-featured thermal cycler that eliminates the need to choose between well-known features of other main PCR instruments. The Agilent SureCycler 8800 delivers high velocity and high volume in the same device, so users aren’t pressured to choose between the two . The modular design accommodates both 96-well and 384-well microtiter plates for additional versatility. The instrument features temperature gradient capability without sacrificing market-leading uniformity also.

Data reported at the meeting are from sufferers who received AG-120 administered from 200 mg to 1200 mg total daily dosages in the dosage escalation arm. The median age group of the patients is 56 . More than half of the individuals enrolled had high-quality tumors and received a median of three prior lines of therapy . Security Data The safety analysis conducted for all 62 treated patients by September 3, 2015 demonstrated that AG-120 was well tolerated with a favorable protection profile in advanced solid tumors including glioma, Chondrosarcoma and IHCC. Specifically the analysis showed: No dosage limiting toxicities have been observed.